Search

Search Results

• Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  229-241

  09.06.2023

• The Use of Pomalidomide in the Treatment of Relapsed/Refractory Multiple Myeloma in Patients with Renal Failure

  Irina Germanovna Rekhtina, M.V. Nareiko, L.P. Mendeleeva

  283-287

  01.10.2018

• New Possibilities of Treatment for Relapsed/Refractory Multiple Myeloma: A Literature Review

  Ol’ga Mikhailovna Votyakova

  425-434

  01.10.2017

• Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma

  Aleksei Vladilenovich Petrov, D.V. Motorin, O.S. Pokrovskaya, E.S. Urnova, M.V. Nareiko, D.V. Babenetskaya, Yu.A. Alekseeva, L.L. Girshova, L.P. Mendeleeva, A.Yu. Zaritskii

  372-380

  01.07.2017

• Pomalidomide for Treatment of Relapsed and Refractory Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  379-389

  01.10.2015

• Management of relapsed and refractory multiple myeloma: literature review and our data. Part III

  S.S. Bessmeltsev

  137-174

  01.04.2014